We just received data on a new analyst forecast for $ORIC. Robert Burns from HC Wainwright & Co. set a price target of 25.0 for ORIC.
To track analyst ratings and price targets for $ORIC, check out Quiver Quantitative's $ORIC forecast page.
Should you buy $ORIC?
Some analysts are better than others. To view the past performance of HC Wainwright & Co., check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$ORIC Price Targets
Multiple analysts have issued price targets for $ORIC recently. We have seen 8 analysts offer price targets for $ORIC in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $25.0 on 03/13/2026
- David Nierengarten from Wedbush set a target price of $20.0 on 02/24/2026
- Yigal Nochomovitz from Citigroup set a target price of $17.0 on 02/24/2026
- Kelsey Goodwin from Piper Sandler set a target price of $22.0 on 01/07/2026
- Derek Archila from Wells Fargo set a target price of $25.0 on 12/08/2025
- Cory Kasimov from Evercore ISI Group set a target price of $25.0 on 11/20/2025
- Anupam Rama from JP Morgan set a target price of $20.0 on 11/18/2025
$ORIC Insider Trading Activity
$ORIC insiders have traded $ORIC stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $ORIC stock by insiders over the last 6 months:
- JACOB CHACKO (PRESIDENT AND CEO) has made 0 purchases and 5 sales selling 283,374 shares for an estimated $3,167,380.
- DOMINIC PISCITELLI (Chief Financial Officer) has made 0 purchases and 3 sales selling 73,720 shares for an estimated $959,532.
- PRATIK S MULTANI (Chief Medical Officer) sold 10,720 shares for an estimated $97,128
- RICHARD A. HEYMAN has made 0 purchases and 2 sales selling 6,700 shares for an estimated $80,430.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ORIC Hedge Fund Activity
We have seen 100 institutional investors add shares of $ORIC stock to their portfolio, and 71 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PARADIGM BIOCAPITAL ADVISORS LP added 2,401,217 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,641,955
- STATE STREET CORP added 1,854,458 shares (+77.1%) to their portfolio in Q4 2025, for an estimated $15,169,466
- CITADEL ADVISORS LLC added 1,236,706 shares (+103.2%) to their portfolio in Q4 2025, for an estimated $10,116,255
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,205,429 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,860,409
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 1,065,334 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,784,008
- GOLDMAN SACHS GROUP INC added 1,034,473 shares (+114.3%) to their portfolio in Q4 2025, for an estimated $8,461,989
- VIVO CAPITAL, LLC removed 1,008,220 shares (-32.2%) from their portfolio in Q4 2025, for an estimated $8,247,239
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
